Amarin Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa(TM) and FDA Approved MARINE Indication Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa(TM) and FDA Approved MARINE Indication
Amarin to Present at the CITI 2012 Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at the CITI 2012 Global Healthcare Conference
Amarin to Report Fourth Quarter and Year-End 2011 Results and Host Conference Call on February 29, 2012 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Report Fourth Quarter and Year-End 2011 Results and Host Conference Call on February 29, 2012
Amarin Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Reports Fourth Quarter and Year-End 2011 Financial Results and Provides Update on Operations
Amarin to Present at the 24th Annual ROTH OC Growth Stock Conference Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at the 24th Annual ROTH OC Growth Stock Conference
Amarin Announces Notification of Patent Allowance for AMR101 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Notification of Patent Allowance for AMR101
Amarin to Report First Quarter 2012 Financial Results and Host Conference Call on May 8, 2012 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Report First Quarter 2012 Financial Results and Host Conference Call on May 8, 2012
Amarin Reports First Quarter 2012 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Reports First Quarter 2012 Financial Results and Provides Update on Operations
Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Data for Amarin's AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions
Amarin Announces U.S. Patent Issuance for AMR101 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces U.S. Patent Issuance for AMR101
